It also has been shown that α-GalCer can act as a strong adjuvant for irradiated tumor cell vaccines when tumor cells are pulsed with α-GalCer prior to irradiation, regardless of the expression of CD1d on tumor cells [99]. The gene discussed is CD1D; the disease is neoplasm.